Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
cardiovascular (20) 20
cardiology and cardiovascular medicine (15) 15
humans (13) 13
female (12) 12
index medicus (12) 12
male (12) 12
middle aged (12) 12
treatment outcome (12) 12
cardiac & cardiovascular systems (10) 10
absorbable implants (9) 9
drug-eluting stents (9) 9
everolimus (9) 9
coronary angiography (8) 8
implantation (8) 8
sirolimus - analogs & derivatives (8) 8
stents (8) 8
time factors (8) 8
aged (7) 7
bioresorbable scaffold (6) 6
coronary vessels (6) 6
internal medicine (6) 6
intravascular ultrasound (6) 6
optical coherence tomography (6) 6
thrombosis (6) 6
cardiovascular agents - administration & dosage (5) 5
coronary artery disease (5) 5
coronary artery disease - therapy (5) 5
sirolimus (5) 5
2nd-generation (4) 4
abridged index medicus (4) 4
absorb (4) 4
angiography (4) 4
angioplasty (4) 4
angioplasty, balloon, coronary - adverse effects (4) 4
angioplasty, balloon, coronary - instrumentation (4) 4
coronary artery disease - diagnostic imaging (4) 4
drug-eluting stent (4) 4
heart attacks (4) 4
predictive value of tests (4) 4
prospective studies (4) 4
prosthesis design (4) 4
sirolimus - administration & dosage (4) 4
stent (4) 4
angiogenesis inhibitors (3) 3
angioplasty, balloon, coronary (3) 3
atherosclerosis (3) 3
cardiology (3) 3
coronary vessels - diagnostic imaging (3) 3
coronary vessels - pathology (3) 3
follow-up (3) 3
follow-up studies (3) 3
immunosuppressive agents (3) 3
medical imaging (3) 3
medicine, general & internal (3) 3
tissue scaffolds (3) 3
tomography, optical coherence (3) 3
trial (3) 3
ultrasonography, interventional (3) 3
vascular scaffold (3) 3
1st human-experience (2) 2
adult (2) 2
biocompatible materials (2) 2
bioresorbable vascular scaffold (2) 2
bioresorbable vascular scaffolds (2) 2
cardiovascular disease (2) 2
care and treatment (2) 2
clinical trials (2) 2
clinical trials as topic (2) 2
coronary artery disease - mortality (2) 2
coronary disease - diagnostic imaging (2) 2
coronary disease - therapy (2) 2
coronary heart disease (2) 2
coronary restenosis (2) 2
coronary stenosis (2) 2
coronary stenosis - diagnostic imaging (2) 2
coverage (2) 2
creatine (2) 2
creatine kinase (2) 2
europe (2) 2
ivus (2) 2
kaplan-meier estimate (2) 2
lesions (2) 2
lumen (2) 2
metals (2) 2
multi-imaging modality (2) 2
myocardial infarction - etiology (2) 2
myocardial-infarction (2) 2
new zealand (2) 2
percutaneous coronary intervention - adverse effects (2) 2
percutaneous coronary intervention - instrumentation (2) 2
polymer (2) 2
restenosis (2) 2
shear-stress (2) 2
single-blind method (2) 2
studies (2) 2
thickness (2) 2
thrombosis - etiology (2) 2
tomography (2) 2
trials (2) 2
ultrasonography (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text A bioresorbable everolimus-eluting scaffold versus a metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions (ABSORB II): an interim 1-year analysis of clinical and procedural secondary outcomes from a randomised controlled trial
by Serruys, Patrick W, Prof and Chevalier, Bernard, MD and Dudek, Dariusz, MD and Cequier, Angel, MD and Carrié, Didier, MD and Iniguez, Andres, MD and Dominici, Marcello, MD and van der Schaaf, René J, MD and Haude, Michael, MD and Wasungu, Luc, PhD and Veldhof, Susan, RN and Peng, Lei, MSc and Staehr, Peter, MD and Grundeken, Maik J, MD and Ishibashi, Yuki, MD and Garcia-Garcia, Hector M, MD and Onuma, Yoshinobu, MD
Lancet, The, ISSN 0140-6736, 2015, Volume 385, Issue 9962, pp. 43 - 54
Summary Background Despite rapid dissemination of an everolimus-eluting bioresorbable scaffold for treatment for coronary artery disease, no data from... 
Internal Medicine | MEDICINE, GENERAL & INTERNAL | SHEAR-STRESS PATTERNS | VIVO ACUTE STENT | MYOCARDIAL-INFARCTION | OPTICAL COHERENCE TOMOGRAPHY | VASCULAR SCAFFOLD | IMPLANTATION | AMERICAN-COLLEGE | ASSOCIATION TASK-FORCE | MULTI-IMAGING MODALITY | FOLLOW-UP | Single-Blind Method | Prospective Studies | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Male | Tissue Scaffolds | Young Adult | Aged, 80 and over | Adult | Female | Surveys and Questionnaires | Everolimus | Drug-Eluting Stents | Sirolimus - analogs & derivatives | Sirolimus - therapeutic use | Treatment Outcome | Myocardial Ischemia - drug therapy | Absorbable Implants | Coronary Angiography | Adolescent | Quality of Life | Aged | Biocompatible Materials - therapeutic use | Myocardial Ischemia - surgery | Ischemia | Coronary heart disease | Stent (Surgery) | Heart attacks | Medical imaging | Coronary vessels | Cardiovascular disease | Physiology | Nitrates | Cardiology | Stents | Thrombosis | Veins & arteries
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods
by Serruys, Patrick W, Prof and Ormiston, John A, Prof and Onuma, Yoshinobu, MD and Regar, Evelyn, MD and Gonzalo, Nieves, MD and Garcia-Garcia, Hector M, MD and Nieman, Koen, MD and Bruining, Nico, PhD and Dorange, Cécile, MSc and Miquel-Hébert, Karine, PhD and Veldhof, Susan, RN and Webster, Mark, MB and Thuesen, Leif, MD and Dudek, Dariusz, MD
Lancet, The, ISSN 0140-6736, 2009, Volume 373, Issue 9667, pp. 897 - 910
Summary Background Drug-eluting metallic coronary stents predispose to late stent thrombosis, prevent late lumen vessel enlargement, hinder surgical... 
Internal Medicine | TRIAL | TOMOGRAPHY | MEDICINE, GENERAL & INTERNAL | ANGIOGRAPHY | INTRACORONARY ULTRASOUND | ANGIOPLASTY | 3-DIMENSIONAL INTRAVASCULAR ULTRASOUND | IMPLANTATION | ARTERY LESIONS | ATHEROSCLEROTIC PLAQUE COMPOSITION | LUMEN | Sirolimus - analogs & derivatives | Immunosuppressive Agents | Follow-Up Studies | Humans | Middle Aged | Coronary Restenosis - prevention & control | Male | Treatment Outcome | Clinical Trials as Topic | Absorbable Implants | Drug-Eluting Stents - adverse effects | Multicenter Studies as Topic | Coronary Disease - diagnostic imaging | Coronary Disease - therapy | Ultrasonography | Female | Everolimus | Coronary Restenosis - etiology | Usage | Patient outcomes | Endovascular stents | Studies | Heart attacks | Medical imaging | Stents | Coronary vessels
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text A bioabsorbable everolimus-eluting coronary stent system for patients with single de-novo coronary artery lesions (ABSORB): a prospective open-label trial
by Ormiston, John A, MB and Serruys, Patrick W, Prof and Regar, Evelyn, MD and Dudek, Dariusz, MD and Thuesen, Leif, MD and Webster, Mark WI, MB and Onuma, Yoshinobu, MD and Garcia-Garcia, Hector M, MD and McGreevy, Robert, PhD and Veldhof, Susan, RN
Lancet, The, ISSN 0140-6736, 2008, Volume 371, Issue 9616, pp. 899 - 907
Summary Background A fully bioabsorbable drug-eluting coronary stent that scaffolds the vessel wall when needed and then disappears once the acute recoil and... 
Internal Medicine | MEDICINE, GENERAL & INTERNAL | MULTICENTER | 6-MONTH | THROMBOSIS | COVERAGE | POLYMER | 1ST HUMAN-EXPERIENCE | FOLLOW-UP | INTRAVASCULAR ULTRASOUND | II TRIAL | INSIGHTS | Drug-Eluting Stents | Sirolimus - analogs & derivatives | Immunosuppressive Agents | Prospective Studies | Humans | Middle Aged | Coronary Restenosis | Male | Absorbable Implants | Angioplasty, Balloon, Coronary | Coronary Disease - diagnostic imaging | Coronary Disease - therapy | Ultrasonography | Female | Safety | Everolimus | Clinical trials | Heart attacks | Angioplasty | Stents | Coronary vessels
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Relation Between Bioresorbable Scaffold Sizing Using QCA-Dmax and Clinical Outcomes at 1 Year in 1,232 Patients From 3 Study Cohorts (ABSORB Cohort B, ABSORB EXTEND, and ABSORB II)
by Ishibashi, Yuki, MD, PhD and Nakatani, Shimpei, MD and Sotomi, Yohei, MD and Suwannasom, Pannipa, MD and Grundeken, Maik J., MD and Garcia-Garcia, Hector M., MD, PhD and Bartorelli, Antonio L., MD and Whitbourn, Robert, MD and Chevalier, Bernard, MD and Abizaid, Alexandre, MD, PhD and Ormiston, John A., MB, ChB, PhD and Rapoza, Richard J., PhD and Veldhof, Susan, RN and Onuma, Yoshinobu, MD, PhD and Serruys, Patrick W., MD, PhD
JACC: Cardiovascular Interventions, ISSN 1936-8798, 2015, Volume 8, Issue 13, pp. 1715 - 1726
Abstract Objectives This study sought to investigate the clinical outcomes based on the assessment of quantitative coronary angiography–maximal lumen diameter... 
Cardiovascular | maximal lumen diameter | major adverse cardiac event(s) | bioresorbable scaffold | major adverse cardiac event(s) | maximal lumen diameter | CORONARY STENT SYSTEM | TRIALS | CARDIAC & CARDIOVASCULAR SYSTEMS | MYOCARDIAL-INFARCTION | OPTICAL COHERENCE TOMOGRAPHY | VASCULAR SCAFFOLD | THROMBOSIS | APPROPRIATE DEPLOYMENT | IMPLANTATION | 2ND-GENERATION | Coronary Vessels - diagnostic imaging | Multivariate Analysis | Predictive Value of Tests | Percutaneous Coronary Intervention - mortality | Humans | Middle Aged | Risk Factors | Kaplan-Meier Estimate | Logistic Models | Male | Treatment Outcome | Coronary Artery Disease - mortality | Prosthesis Design | Absorbable Implants | Coronary Angiography | Coronary Artery Disease - diagnostic imaging | Percutaneous Coronary Intervention - instrumentation | Coronary Artery Disease - therapy | Time Factors | Female | Aged | Odds Ratio | Myocardial Infarction - etiology | Percutaneous Coronary Intervention - adverse effects
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Natural History of Coronary Atherosclerosis by Multislice Computed Tomography
by Papadopoulou, Stella-Lida, MD and Neefjes, Lisan A., MD and Garcia-Garcia, Hector M., MD, PhD and Flu, Willem-Jan, MD, PhD and Rossi, Alexia, MD and Dharampal, Anoeshka S., MD and Kitslaar, Pieter H., MSc and Mollet, Nico R., MD, PhD and Veldhof, Susan, RN and Nieman, Koen, MD, PhD and Stone, Gregg W., MD and Serruys, Patrick W., MD, PhD and Krestin, Gabriel P., MD, PhD and de Feyter, Pim J., MD, PhD
JACC: Cardiovascular Imaging, ISSN 1936-878X, 2012, Volume 5, Issue 3, pp. S28 - S37
Objectives This study sought to analyze the natural history of coronary atherosclerosis by multislice computed tomography (MSCT) and assess the serial changes... 
Cardiovascular | atherosclerosis | coronary plaque | disease progression | computed tomography coronary angiography | REGRESSION | CARDIAC & CARDIOVASCULAR SYSTEMS | LEFT MAIN | LIPID-LOWERING THERAPY | PLAQUE | ANGIOGRAPHY | ARTERIES | COMPENSATORY ENLARGEMENT | DISEASE | INTRAVASCULAR ULTRASOUND | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | PROGRESSION | Plaque, Atherosclerotic - diagnostic imaging | Predictive Value of Tests | United States - epidemiology | Prospective Studies | Humans | Middle Aged | Ultrasonography, Interventional | Vascular Calcification - diagnostic imaging | Male | Plaque, Atherosclerotic - epidemiology | Tomography, X-Ray Computed | Angioplasty, Balloon, Coronary - adverse effects | Coronary Angiography - methods | Time Factors | Adult | Female | Coronary Stenosis - epidemiology | Coronary Stenosis - diagnostic imaging | Severity of Illness Index | Reproducibility of Results | Coronary Stenosis - therapy | Europe - epidemiology | Treatment Outcome | Disease Progression | Coronary Artery Disease - diagnostic imaging | Coronary Artery Disease - therapy | Plaque, Atherosclerotic - therapy | Vascular Calcification - epidemiology | Coronary Artery Disease - epidemiology | Observer Variation
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Serial Analysis of the Malapposed and Uncovered Struts of the New Generation of Everolimus-Eluting Bioresorbable Scaffold With Optical Coherence Tomography
by Gomez-Lara, Josep, MD and Radu, Maria, MD and Brugaletta, Salvatore, MD and Farooq, Vasim, MBChB and Diletti, Roberto, MD and Onuma, Yoshinobu, MD and Windecker, Stephan, MD and Thuesen, Leif, MD and McClean, Dougal, MD and Koolen, Jacques, MD, PhD and Whitbourn, Robert, MD and Dudek, Dariusz, MD and Smits, Pieter C., MD, PhD and Regar, Evelyn, MD, PhD and Veldhof, Susan, RN and Rapoza, Richard, PhD and Ormiston, John A., MBChB, PhD and Garcia-Garcia, Hector M., MD, PhD and Serruys, Patrick W., MD, PhD
JACC: Cardiovascular Interventions, ISSN 1936-8798, 2011, Volume 4, Issue 9, pp. 992 - 1001
Objectives The aim of this study is to assess the serial changes in strut apposition and coverage of the bioresorbable vascular scaffolds (BVS) and to relate... 
Cardiovascular | incomplete stent | strut apposition | uncovered struts | late acquired incomplete stent | optical coherence tomography | bioresorbable scaffolds | CARDIAC & CARDIOVASCULAR SYSTEMS | NEOINTIMAL COVERAGE | THROMBOSIS | VASCULAR-RESPONSE | BARE-METAL | INCOMPLETE STENT APPOSITION | IMPLANTATION | TERM-FOLLOW-UP | INTRAVASCULAR ULTRASOUND | ABSORB | 2ND-GENERATION | Cardiovascular Agents - administration & dosage | Drug-Eluting Stents | Sirolimus - analogs & derivatives | Angioplasty, Balloon, Coronary - instrumentation | Tomography, Optical Coherence | United States | Europe | Humans | Middle Aged | Male | Treatment Outcome | Prosthesis Design | New Zealand | Angioplasty, Balloon, Coronary - adverse effects | Sirolimus - administration & dosage | Time Factors | Thrombosis - etiology | Biocompatible Materials | Female | Aged | Thrombosis - prevention & control | Australia | Everolimus | Thrombosis - diagnosis
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text 1-Year Clinical Outcomes of Diabetic Patients Treated With Everolimus-Eluting Bioresorbable Vascular Scaffolds
by Muramatsu, Takashi, MD, PhD and Onuma, Yoshinobu, MD and van Geuns, Robert-Jan, MD, PhD and Chevalier, Bernard, MD and Patel, Tejas M., MD and Seth, Ashok, MD and Diletti, Roberto, MD and García-García, Hector M., MD, PhD and Dorange, Cécile C., MSc and Veldhof, Susan, RN and Cheong, Wai-Fung, PhD and Ozaki, Yukio, MD, PhD and Whitbourn, Robert, MD and Bartorelli, Antonio, MD and Stone, Gregg W., MD and Abizaid, Alexandre, MD, PhD and Serruys, Patrick W., MD, PhD and ABSORB Cohort B ABSORB Extend & SP
JACC: Cardiovascular Interventions, ISSN 1936-8798, 2014, Volume 7, Issue 5, pp. 482 - 493
Objectives The aim of this study was to evaluate 1-year clinical outcomes of diabetic patients treated with the Absorb bioresorbable vascular scaffold (BVS).... 
Cardiovascular | coronary artery disease | bioresorbable scaffold | diabetes mellitus | drug-eluting stent | EUROPEAN-ASSOCIATION | REVASCULARIZATION | CARDIAC & CARDIOVASCULAR SYSTEMS | TASK-FORCE | IMPLANTATION | THROMBOSIS | PERCUTANEOUS CORONARY | GUIDELINES | CARDIOLOGY ESC | STENT TRIALS | CORONARY-ARTERY-DISEASE
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Vasomotor Response to Nitroglycerine Over 5 Years Follow-Up After Everolimus-Eluting Bioresorbable Scaffold Implantation
by Dudek, Dariusz, MD, PhD and Rzeszutko, Łukasz, MD, PhD and Onuma, Yoshinobu, MD, PhD and Sotomi, Yohei, MD and Depukat, Rafał and Veldhof, Susan, RN and Ediebah, Divine, MS and Staehr, Peter, MD and Zasada, Wojciech, MD, PhD and Malinowski, Krzysztof P., MS and Kaluza, Grzegorz L., MD, PhD and Serruys, Patrick W., MD, PhD
JACC: Cardiovascular Interventions, ISSN 1936-8798, 2017, Volume 10, Issue 8, pp. 786 - 795
Abstract Objectives This study investigated the vasomotor response to nitroglycerine (NTG) up to 5 years after ABSORB implantation. Background There are no... 
Cardiovascular | vasomotion | bioresorbable scaffold | ABSORB | SYSTEM | CARDIAC & CARDIOVASCULAR SYSTEMS | TERM ENDOTHELIAL DYSFUNCTION | VASCULAR SCAFFOLD | MULTI-IMAGING MODALITY | STENT | BALLOON ANGIOPLASTY | OUTCOMES | 2ND-GENERATION | VASOCONSTRICTION | STENOTIC CORONARY-ARTERIES | Coronary Vessels - diagnostic imaging | Coronary Vessels - physiopathology | Humans | Ultrasonography, Interventional | Vasomotor System - drug effects | Everolimus - administration & dosage | Percutaneous Coronary Intervention - instrumentation | Coronary Artery Disease - physiopathology | Time Factors | Vasomotor System - physiopathology | Everolimus - adverse effects | Nitroglycerin - administration & dosage | Cardiovascular Agents - administration & dosage | Coronary Vessels - drug effects | Treatment Outcome | Coated Materials, Biocompatible | Vasoconstriction - drug effects | Absorbable Implants | Coronary Angiography | Coronary Artery Disease - diagnostic imaging | Coronary Artery Disease - therapy | Vasodilation - drug effects | Cardiovascular Agents - adverse effects | Percutaneous Coronary Intervention - adverse effects | Vasodilator Agents - administration & dosage
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text A Comparison of the Conformability of Everolimus-Eluting Bioresorbable Vascular Scaffolds to Metal Platform Coronary Stents
by Gomez-Lara, Josep, MD and Garcia-Garcia, Hector M., MD, PhD and Onuma, Yoshinobu, MD and Garg, Scot, MB, ChB and Regar, Evelyn, MD, PhD and De Bruyne, Bernard, MD, PhD and Windecker, Stefan, MD and McClean, Dougal, MD and Thuesen, Leif, MD and Dudek, Dariusz, MD and Koolen, Jacques, MD, PhD and Whitbourn, Robert, MD and Smits, Pieter C., MD, PhD and Chevalier, Bernard, MD and Dorange, Cécile, MSc and Veldhof, Susan, RN and Morel, Marie-Angèle, BSc and de Vries, Ton, MSc and Ormiston, John A., MB, ChB, PhD and Serruys, Patrick W., MD, PhD
JACC: Cardiovascular Interventions, ISSN 1936-8798, 2010, Volume 3, Issue 11, pp. 1190 - 1198
Objectives The aim of this study was to assess the differences in terms of curvature and angulation of the treated vessel after the deployment of either a... 
Cardiovascular | stent | conformability | bioresorbable | angulation | curvature | CARDIAC & CARDIOVASCULAR SYSTEMS | FLEXIBILITY | LESIONS | FRACTURE | IMPLANTATION | PREDICTORS | SHEAR-STRESS | RESTENOSIS | ARTERY | ABSORB | THICKNESS | Predictive Value of Tests | Cardiovascular Agents - administration & dosage | Coronary Vessels - pathology | Drug-Eluting Stents | Sirolimus - analogs & derivatives | Angioplasty, Balloon, Coronary - instrumentation | Humans | Metals | Middle Aged | Male | Treatment Outcome | Clinical Trials as Topic | Prosthesis Design | Coronary Angiography | Sirolimus - administration & dosage | Biocompatible Materials | Female | Aged | Retrospective Studies | Software | Everolimus | Radiographic Image Interpretation, Computer-Assisted | Stents
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text 6-Month Clinical Outcomes Following Implantation of the Bioresorbable Everolimus-Eluting Vascular Scaffold in Vessels Smaller or Larger Than 2.5 mm
by Diletti, Roberto, MD and Onuma, Yoshinobu, MD and Farooq, Vasim, MBChB and Gomez-Lara, Josep, MD and Brugaletta, Salvatore, MD and van Geuns, Robert Jan, MD, PhD and Regar, Evelyn, MD, PhD and de Bruyne, Bernard, MD and Dudek, Dariusz, MD and Thuesen, Leif, MD and Chevalier, Bernard, MD and McClean, Dougal, MD and Windecker, Stephan, MD, PhD and Whitbourn, Robert, MD and Smits, Pieter, MD, PhD and Koolen, Jacques, MD and Meredith, Ian, MBBS, PhD and Li, Dong, MSc and Veldhof, Susan, RN and Rapoza, Richard, PhD and Garcia-Garcia, Hector M., MD, PhD and Ormiston, John A., MBChB, PhD and Serruys, Patrick W., MD, PhD
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2011, Volume 58, Issue 3, pp. 258 - 264
Objectives We investigated the 6-month clinical outcomes after implantation of second-generation 3.0-mm bioresorbable everolimus-eluting vascular scaffolds... 
Cardiovascular | Internal Medicine | outcome | small vessels | bioresorbable everolimus-eluting vascular scaffold | TRIALS | CARDIAC & CARDIOVASCULAR SYSTEMS | STRUT THICKNESS | RESTENOSIS | CORONARY STENT | RECOIL | Coronary Vessels - diagnostic imaging | Coronary Vessels - pathology | Drug-Eluting Stents | Sirolimus - analogs & derivatives | Endosonography | Tomography, Optical Coherence | Humans | Middle Aged | Male | Treatment Outcome | Absorbable Implants | Tissue Scaffolds | Coronary Angiography | Female | Everolimus | Creatine | Creatine kinase | Cardiology | Angiogenesis inhibitors | Studies | Heart attacks | Coronary vessels | Clinical outcomes
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Head-to-Head Comparison of the Neointimal Response Between Metallic and Bioresorbable Everolimus-Eluting Scaffolds Using Optical Coherence Tomography
by Gomez-Lara, Josep, MD and Brugaletta, Salvatore, MD and Farooq, Vasim, MBChB and Onuma, Yoshinobu, MD and Diletti, Roberto, MD and Windecker, Stephan, MD and Thuesen, Leif, MD and McClean, Dougal, MD and Koolen, Jacques, MD, PhD and Whitbourn, Robert, MD and Dudek, Dariusz, MD and Smits, Pieter C., MD, PhD and Chevalier, Bernard, MD and Regar, Evelyn, MD, PhD and Veldhof, Susan, RN and Rapoza, Richard, PhD and Ormiston, John A., MBChB and Garcia-Garcia, Hector M., MD, PhD and Serruys, Patrick W., MD, PhD
JACC: Cardiovascular Interventions, ISSN 1936-8798, 2011, Volume 4, Issue 12, pp. 1271 - 1280
The metallic everolimus drug-eluting stents (DES) and polymeric everolimus bioresorbable vascular scaffolds (BVS) are coated with the same antiproliferative... 
Cardiovascular | bioresorbable vascular scaffold | optical coherence tomography | stent/scaffold thrombosis | minimal lumen diameter | drug-eluting stent(s) | neointimal thickness | CARDIAC & CARDIOVASCULAR SYSTEMS | THROMBOSIS | COVERAGE | FOLLOW-UP | CORONARY-ARTERIES | TRIAL | STENT IMPLANTATION | DUAL ANTIPLATELET THERAPY | VASCULAR SCAFFOLDS | INTRAVASCULAR ULTRASOUND | 2ND-GENERATION | Predictive Value of Tests | Coronary Stenosis - etiology | Angioplasty, Balloon, Coronary - instrumentation | Humans | Metals | Middle Aged | Male | Prosthesis Design | Angioplasty, Balloon, Coronary - adverse effects | Coronary Stenosis - prevention & control | Time Factors | Female | Everolimus | Cardiovascular Agents - administration & dosage | Coronary Vessels - pathology | Drug-Eluting Stents | Sirolimus - analogs & derivatives | Tomography, Optical Coherence | Treatment Outcome | Chi-Square Distribution | Absorbable Implants | Coronary Angiography | Coronary Stenosis - pathology | Sirolimus - administration & dosage | Coronary Artery Disease - therapy | Tunica Intima - pathology | Coronary Artery Disease - diagnosis | Aged | Coronary Stenosis - diagnosis
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Efficacy and Safety of the Absorb Everolimus-Eluting Bioresorbable Scaffold for Treatment of Patients With Diabetes Mellitus
by Kereiakes, Dean J., MD and Ellis, Stephen G., MD and Kimura, Takeshi, MD and Abizaid, Alexandre, MD, PhD and Zhao, Weiying, MD, PhD and Veldhof, Susan, RN and Vu, Minh-Thien, MS and Zhang, Zhen, PhD and Onuma, Yoshinobu, MD, PhD and Chevalier, Bernard, MD and Serruys, Patrick W., MD, PhD and Stone, Gregg W., MD
JACC: Cardiovascular Interventions, ISSN 1936-8798, 2016, Volume 10, Issue 1, pp. 42 - 49
Abstract Objectives The study sought to evaluate the efficacy and safety of the Absorb everolimus-eluting bioresorbable vascular scaffold (BVS) (Abbott... 
Cardiovascular | coronary artery disease | bioresorbable vascular scaffolds | diabetes
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text A Polylactide Bioresorbable Scaffold Eluting Everolimus for Treatment of Coronary Stenosis
by Serruys, Patrick W., MD, PhD and Ormiston, John, MBChB, PhD and van Geuns, Robert-Jan, MD, PhD and de Bruyne, Bernard, MD, PhD and Dudek, Dariusz, MD and Christiansen, Evald, MD and